DRL to buy back Perlecan stake from ICICI Vent, Citi: Srcs
Published on Mon, Jul 21 at 15:20 , Updated at Mon, Jul 21 at 17:54
Source : Sources
| ads by google |
Dr Reddy's will hold 100% stake in Perlecan Pharma post the buyback sources said. Perlecan had dropped three new chemical entities from research, sources added. |
Messages on Business Talk
Other comments
Ranbaxy open offer subscribed over 2 times
Daiichi's open offer for Ranbaxy closed today. The offer got subscribed by over two times. Life Insurance Corporati...
in Business Talk - MMB Messenger at 07-Sep-08 01:06
Best listed Indian companies: Forbes
10 Best listed Indian companies: Forbes. 1. BHEL 2. Bharti Airtel 3. HDFC Bank 4. Infosys 5. ITC ...
in Business Talk - TradeMore at 06-Sep-08 11:48
Rate this article
News
05-09 Dr Reddy’s, US co in pact for derma...
19-08 DRL to form new derma co in US: Pha...
Notices
04-09 Dr. Reddy'S Laboratories Ltd. has i...
04-09 Dr Reddys Laboratories Ltd has info...
Expert Advice
18-08 Will mkts unwind more from hereon?...
Management Interviews
18-08 Pathare family stake now at 65%: Ma...
11-08 Dr Reddy's Lab, Teva settle patent ...
Brokerage Reports
26-07 Accumulate Dr Reddys Laboratories, ...
23-07 Dr Reddys Laboratories a market per...
Technical Calls
No Technical Calls on Dr Reddys Labs
Chat
SP Tulsian
Investment Advisor ,
(08 Sep- 13:00hrs)
NSG & its impact on markets
Poll
Newsletter
Keep in touch with News day & night. Subscribe to:
Mobile Services
Get news on the move SMS to 52622
- SMS M for Market News
- SMS B for Latest Business News
- SMS S (stock name) for latest news




Offline





